Hypertension Diagnostics Stock Retained Earnings
Hypertension Diagnostics fundamentals help investors to digest information that contributes to Hypertension Diagnostics' financial success or failures. It also enables traders to predict the movement of Hypertension Pink Sheet. The fundamental analysis module provides a way to measure Hypertension Diagnostics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Hypertension Diagnostics pink sheet.
Hypertension |
Hypertension Diagnostics Company Retained Earnings Analysis
Hypertension Diagnostics' Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
More About Retained Earnings | All Equity Analysis
Retained Earnings | = | Beginning RE + Income | - | Dividends |
Current Hypertension Diagnostics Retained Earnings | (30.68 M) |
Most of Hypertension Diagnostics' fundamental indicators, such as Retained Earnings, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hypertension Diagnostics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
CompetitionBased on the latest financial disclosure, Hypertension Diagnostics has a Retained Earnings of (30.68 Million). This is 100.2% lower than that of the Health Care Equipment & Supplies sector and significantly lower than that of the Health Care industry. The retained earnings for all United States stocks is 100.33% higher than that of the company.
Hypertension Retained Earnings Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Hypertension Diagnostics' direct or indirect competition against its Retained Earnings to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Hypertension Diagnostics could also be used in its relative valuation, which is a method of valuing Hypertension Diagnostics by comparing valuation metrics of similar companies.Hypertension Diagnostics is currently under evaluation in retained earnings category among its peers.
Hypertension Fundamentals
Return On Asset | 3.0E-4 | ||||
Profit Margin | (0.03) % | ||||
Operating Margin | 0.0002 % | ||||
Current Valuation | 5.26 M | ||||
Shares Outstanding | 52.39 M | ||||
Price To Earning | (0.03) X | ||||
Price To Sales | 0.15 X | ||||
Revenue | 3.79 M | ||||
Gross Profit | 954.47 K | ||||
EBITDA | 72.29 K | ||||
Net Income | (125.39 K) | ||||
Cash And Equivalents | 5.66 K | ||||
Total Debt | 4.69 M | ||||
Current Ratio | 0.52 X | ||||
Book Value Per Share | (0.09) X | ||||
Cash Flow From Operations | (389.28 K) | ||||
Earnings Per Share | (0) X | ||||
Beta | -0.92 | ||||
Market Capitalization | 730.42 K | ||||
Total Asset | 1.28 M | ||||
Retained Earnings | (30.68 M) | ||||
Working Capital | (857 K) | ||||
Current Asset | 277 K | ||||
Current Liabilities | 1.13 M | ||||
Z Score | -31.6 | ||||
Net Asset | 1.28 M |
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in Hypertension Pink Sheet
If you are still planning to invest in Hypertension Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hypertension Diagnostics' history and understand the potential risks before investing.
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |